Multivariate analysis including all baseline and operative covariates of 291 patients who received PCC demonstrated that the dose of PCC was not associated with any of the main outcome end-points, other than bleeding and use of blood products.
Main Outcome Measures: Motor point recovery per extremity and percentage recovery per extremity.
In addition to the main outcome measures, data points related to the patient, surgeon, operation, hospital, operative method and postoperative period will be collected (table 1).
Main outcome measures Primary end point: cumulative incidence of cervical intraepithelial neoplasia grade II or more severe disease.
At each of the five stations, a maximum of 40 points (36 points on technical skills and 4 points on communication skills) were obtainable, totalling a maximum score of 200 points (main outcome measure).
Main outcome measures Planned end points were cumulative incidence and mortality of colorectal cancer after 5, 10, and 15 years.
Main outcome measures Primary end points: three year and five year cumulative incidence of histologically confirmed cervical intraepithelial neoplasia grade II+ (n=70).
Main outcome measures Clinical end points: cumulative incidence of cervical intraepithelial neoplasia grade II or worse and grade III or worse at three years.
We also extracted from each study, if available, a continuous and a dichotomous main outcome at two time points (intermediate and late), and a continuous and a dichotomous pain outcome (when applicable).
Main outcome measures The primary end point was attendance for screening.
